Thymalin

Thymalin is not a single molecule but a mixture. The calf thymus extract contains several low-molecular peptides and has served the Russian research tradition as an immune modulator since the 1970s. It was developed and studied chiefly by the Khavinson school at the Institute of Bioregulation and Gerontology in St. Petersburg, which described a whole family of so-called bioregulators, epitalon among them.

That sets thymalin apart from single synthetic peptides such as thymosin alpha-1 or KPV: the mixture covers several mechanisms at once but makes it harder to tie effects to molecules.

Findings from the literature:

• In preclinical studies thymalin promoted T-cell differentiation, activated immune cells and influenced thymic function; animal models described a recovery of the age-related decline in thymic function, hence its appearance in ageing research.
• A 1997 paper describes, alongside the extract, the dipeptide Glu-Trp isolated from it; both spurred T-cell differentiation and changed cytokine release from blood lymphocytes.
• In a 2020 study on human blood-forming stem cells, thymalin cut CD44 and CD117 expression by a factor of two to three while the T-cell marker CD28 rose 6.8-fold, read by the authors as indirect evidence of differentiation.
• A 2010 review by the bioregulator school reports that rodents given such peptide preparations lived longer on average and developed fewer tumours, based on the authors' own long-term data.

Much of the evidence exists only in Russian, which has slowed its international reception. Here you find thymalin strictly as a research compound; this is context, not a guide.

Thymalin is regarded as well tolerated in the available studies. The particularities of an organ extract remain:

• Injection site: mild redness or tenderness is the most common local observation.
• Intervention in the immune system: the extract changes T-cell differentiation and thymic function, that is, adaptive immunity itself.
• Origin and composition: as a mixture from calf thymus rather than a defined single peptide, its composition varies from batch to batch, and individual effects are harder to separate mechanistically.
• Evidence base: the evidence comes mostly from Russian-language literature; robust international long-term data in humans are largely missing.

This summary is no substitute for medical advice.

• Natural and synthetic thymic peptides as therapeutics for immune dysfunction - 1997 paper on the extract and the dipeptide Glu-Trp isolated from it.
• Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells - 2020 stem cell study with the markers CD44, CD117 and CD28.
• Peptide bioregulation of aging: results and prospects - 2010 review from the bioregulator school on organ peptides and life span in rodents.